TP53BP1 and cancer: More generally, this work supports the use of PBMCs and DNA damage-sensing protein 53BP1 expression as a minimally invasive astronaut monitoring tool to identify and to anticipate potential health impairments during long-term spaceflight from a simple finger prick, as well as a potential predictive metric of cellular damage for cancer radiotherapy.